Clinical Trials · NCT07872904

FutureShape Family

Not Yet RecruitingPhase 4Semaglutide (Investigational)
Phase
Phase 4
Recruitment status
Not Yet Recruiting
Sponsor
Signe Torekov
Enrollment
400
Start date
Oct 2026
Locations
1 site, Denmark
Primary endpoint
Change in body fat percentage
View Semaglutide compound reference